This bill prohibits the President from declaring federal emergencies under three key laws (the National Emergencies Act, Public Health Service Act, and Stafford Act) for purposes related to abortion. Specifically, it blocks emergency declarations meant to promote, support, or expand abortion access, or to take legal action against states that restrict abortion. The bill defines "abortion" as intentionally terminating a pregnancy (with limited exceptions for live birth or health) using instruments, medicine, or devices. It directly affects federal emergency powers, preventing their use to advance abortion policy or challenge state abortion laws. The law does not change existing abortion regulations but restricts how emergency declarations can be utilized.
HR 683 (PASS Act of 2023) expands the Committee on Foreign Investment in the United States (CFIUS) review process to cover foreign investments in U.S. agriculture businesses, agricultural biotechnology, and private farmland. It mandates that the President block transactions involving foreign entities from China, Russia, Iran, or North Korea that would give them control over U.S. agricultural operations or land used for farming. The bill allows limited presidential waivers for national security reasons but requires a 30-day review period before any waiver. Additionally, it requires the Secretary of Agriculture to submit biannual reports to Congress on risks posed by foreign ownership in U.S. agriculture.
HR 656, the "Head Start for Our Future Act," amends the Higher Education Act to update a funding provision. It replaces the phrase "literacy training" with "child development and early learning (including Head Start programs and Early Head Start programs)" in Section 441(c)(1). This change explicitly directs funds under that section toward early childhood development services, including existing Head Start and Early Head Start programs. The bill does not create new funding but clarifies that these programs qualify for related support.
The Restoring Military Focus Act (HR 678) repeals the Chief Diversity Officer position in the Department of Defense and prohibits the creation of similar roles. It specifically eliminates two existing positions: the Chief Diversity Officer (under pre-2021 Title 10, U.S. Code) and the Senior Advisor for Diversity and Inclusion (under the 2021 National Defense Authorization Act). The bill bans federal funding for any new position that matches or closely resembles these roles. This directly affects the Department of Defense's organizational structure by removing diversity-focused leadership roles and preventing their replacement.
HR 290, the Commercial Remote Sensing Amendment Act of 2023, modifies reporting requirements for commercial remote sensing licensees under U.S. law. It shortens the annual report deadline from 120 to 60 days, adds new requirements to report license conditions and tiered application/license categories, and extends the sunset date for these provisions from 2020 to 2030. The bill directly affects companies holding commercial remote sensing licenses by changing how they submit annual reports to the government. These changes streamline reporting timelines and add specific data points licensees must include in their submissions. The law makes no new policy changes but adjusts existing administrative processes for the remote sensing industry.
This symbolic House resolution (HRES 72) recognizes independent workers, contractors, and freelancers for their economic contributions to the U.S. It highlights their role in the growing flexible work economy and acknowledges the benefits of flexible work arrangements, such as freedom in hours and locations. The resolution does not create new laws or alter existing policies - it solely serves as a formal acknowledgment of these workers' significance to the economy. It references their $1.35 trillion economic contribution in 2022 and their growing share of the workforce (39% of U.S. workers).
This bill would prevent government shutdowns by automatically continuing funding for most federal programs at the previous fiscal year's level if Congress fails to pass a full budget by the start of the new fiscal year. The automatic funding would continue in 14-day increments until a budget is enacted, with the government returning to normal funding levels once a budget is passed. During these automatic funding periods, government employees (including congressional staff) would face restrictions on travel, with limited exceptions for returning to Washington, D.C. or responding to national security events. The bill also establishes specific procedures for Congress to prioritize budget negotiations during these periods. This would affect the entire federal government and its operations during budget stalemates.
HRES 68 is a symbolic resolution supporting National Catholic Schools Week, which recognizes Catholic schools' educational and community contributions. It does not create new policies or funding but formally endorses the week's goals - highlighting Catholic schools' academic achievements, diverse student enrollment, and role in fostering moral development. The resolution was introduced by multiple House members and passed without opposition, focusing on acknowledgment rather than legislative action. It directly affects Catholic schools by affirming their nationwide impact, though it has no binding effect on federal programs or resources.
This bill would prohibit the FDA from approving new abortion medications or investigational uses of existing ones. It would restrict currently approved abortion drugs to in-person administration only in clinics, hospitals, or medical offices by certified providers who can handle complications like ectopic pregnancy or severe bleeding. The law requires detailed adverse event reporting (excluding patient identifiers) to the FDA by both manufacturers and prescribers, and mandates provider certification covering pregnancy assessment, surgical intervention capabilities, and patient safety documentation. These provisions apply directly to healthcare providers, patients seeking medication abortions, and manufacturers of abortion drugs.
This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits any similar changes in the future.
Protecting Life from Chemical Abortions Act This bill nullifies certain changes made by the Food and Drug Administration (FDA) to dispensing requirements for mifepristone. (Mifepristone is a drug that is approved to end pregnancies through 10 weeks gestation when used in conjunction with the drug misoprostol. The procedure is often referred to as medication abortion or the abortion pill.) The FDA regulates the use of mifepristone through the Mifepristone Risk Evaluation and Mitigation Strategy (REMS) program. The program requires health care providers to comply with certain requirements in order to prescribe or dispense mifepristone to end a pregnancy; the program previously included an in-person dispensing requirement that required mifepristone to be directly dispensed to patients in clinics, medical offices, or hospitals. During the COVID-19 public health emergency, the FDA temporarily stopped enforcing the in-person dispensing requirement, which allowed mail-order pharmacies to fill and dispense mifepristone prescriptions. In January 2023, the FDA modified program requirements so as to (1) remove the in-person dispensing requirement, and (2) require pharmacies to be certified in the program in order to dispense mifepristone. The modifications allow retail pharmacies, after receiving certification, to dispense mifepristone pursuant to prescriptions that are written by program-certified prescribers. The bill nullifies the January 2023 changes and prohibits the FDA from (1) exercising any enforcement discretion with respect to program requirements, or (2) reducing program protections until every state submits certain data regarding abortions to the Centers for Disease Control and Prevention. The bill also generally prohibits the declaration of a public health emergency with respect to abortions.
The Educational Choice for Children Act creates tax credits for individuals and corporations that contribute to scholarship organizations providing educational scholarships. Individuals can claim a credit up to 10% of their adjusted gross income or $5,000, while corporations can claim up to 5% of taxable income. Scholarships are available to students in households earning no more than 300% of the area median income and can be used for public or private school expenses, including religious schools. The bill establishes a $10 billion annual cap on total contributions with funds allocated on a first-come, first-served basis, and requires scholarship organizations to verify student income and distribute scholarships to multiple students. It also prohibits government control over scholarship organizations and schools, ensuring maximum freedom for these organizations.
